Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. - Wikidata - wikimedia - TriplyDB

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

http://www.wikidata.org/entity/Q42794018

about

Activation of P2X(7) receptor by ATP plays an important role in regulating inflammatory responses during acute viral infection A delicate balance Purinergic signalling and cancer Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies DAMPs from Cell Death to New Life The role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses New era for mucosal mast cells: their roles in inflammation, allergic immune responses and adjuvant development Graft rejection - endogenous or allogeneic?Acute graft-versus-host disease: a bench-to-bedside update.P2X ion channel receptors and inflammation The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host Disease Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases Graft-versus-host disease in paediatric solid organ transplantation: A review of the literature.Purinergic and calcium signaling in macrophage function and plasticity.Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice.Antigen-specific CD8+ T cell feedback activates NLRP3 inflammasome in antigen-presenting cells through perforin.Advances in graft-versus-host disease biology and therapy.Purinergic signaling during inflammation.Extracellular nucleotide and nucleoside signaling in vascular and blood disease Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models.Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors.Identification and characterization of vancomycin-resistant Enterococcus species frequently isolated from laboratory mice.Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.Nucleotide signalling during inflammation Graft-versus-host disease is enhanced by selective CD73 blockade in mice Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity.P2X7 receptor activation impairs exogenous MHC class I oligopeptides presentation in antigen presenting cells.Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD The Warburg effect: evolving interpretations of an established concept Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation.CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection.P2X7 mediates ATP-driven invasiveness in prostate cancer cells.Pathophysiological role of extracellular purinergic mediators in the control of intestinal inflammation.P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice

P2860

Q21134608-F475B700-985E-4D68-8F35-806E15303461 Q24615512-4945C871-2FD4-4092-91E9-2B37FB6D7CDD Q24618782-CD0EC40F-F12E-44B0-A020-9A80C9B7DF4F Q26751959-5501F87C-CA97-48FB-8BE2-19C6B144B4B6 Q26782785-7E9FC11A-A188-4724-8F4E-78EF419F587A Q26824436-0FEE0C90-ADCD-403A-8223-9B79B87F2182 Q26863398-AC695364-1C3C-4401-8CE7-FBEF74D404C4 Q26864415-C50C8E96-D067-4A81-A465-FCFB7C8FFFB4 Q26866523-70885BF8-49D7-40FC-810D-FB884D18D50C Q27687130-6BC40F60-A836-41D0-83CF-26F4227C7A2E Q28066934-5270BAD1-0F76-4734-94D4-042B7F0CB33A Q28068647-12B7B51E-1C56-4AFB-A79E-7D8608C12E3D Q28075204-04FF2F41-CBDE-40FA-863F-E4CA961368FA Q28396823-EB730D95-D56A-470D-8BE2-6499D2AC8B58 Q30250262-3750AB1B-92CE-4974-82E3-5EBBA6DC8F02 Q30301117-D368F93B-A77E-4F79-A62C-C9CFE9364407 Q33697267-13597072-B67B-4213-9A02-E561CD1951E5 Q33761326-CC8C1E4C-8266-40D9-AE7E-19074D4A8BAC Q34031916-2434989E-9FA9-44E8-BD37-ABC37657F294 Q34034751-6FB65CC5-FAF2-4FB0-8CF3-54128B28B34A Q34047834-25965638-D04E-4797-A345-4C8CEFFC1C11 Q34167845-3D5E2333-A2AD-47E7-B3CC-F74E78C53E8F Q34170406-952BB8B5-E49C-4CE3-BBFF-E8508E147E52 Q34209366-344F918B-0811-4456-BCA5-5AAB4F0F533D Q34297567-795C937E-AB6F-405E-8FAB-EB88898E0F1A Q34389812-89D7C65A-A7D6-4FA8-AA32-81D40BE0CB6C Q34420372-A8A2F4AB-2AA2-4FA1-8DE6-DE4B7AC6069E Q34464511-35E6D411-9F24-473D-8140-26480765DF1F Q34631798-E2DFB5FA-69B5-48CF-81CB-C970091BCBFF Q34757980-57FAED45-37E2-4A16-9D98-08B553352165 Q34935396-BFD06613-51EB-403E-9782-AF133F491F60 Q34974093-3C5AF72C-3E78-42F0-BFED-FA28E23AE655 Q35022269-0C2395A7-0F5D-4726-8EDB-DD8A23617E64 Q35084400-1CE63170-D429-4B15-8A08-06A6A1BE32DF Q35169587-9EE4DDC3-4AC1-46C0-BEE3-BDADAB36206B Q35179622-1A29087C-FB94-409F-90DA-9F2164412932 Q35202450-3CC528F9-CE04-4325-AFF5-C3901ABE51AF Q35500124-4AED3A6F-D59F-462F-8EAB-4BDDD2FE7F24 Q35511015-63B1E65C-49B7-4332-8659-C25813994DDA Q35926102-CF3ADDEC-FEA1-4F85-8D18-4248F4ECB933

P2860

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

http://www.wikidata.org/entity/Q42794018

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

@en

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

@nl

type

label

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

@en

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

@nl

prefLabel

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

@en

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

@nl

P1433

Q42794018-31B990FD-375E-4534-90AB-1671F766F930

P1476

Q42794018-430AE067-263D-4A30-A9FA-4C313CD0A93B

P2093

Q42794018-039D4237-329E-4EE3-A77E-CEEC7F22F421

Q42794018-205AA2A2-120D-4159-8289-BB6C923DCA8F

Q42794018-22463F79-956C-47CB-B82F-1C61D86286A6

Q42794018-3456428C-F743-4682-829A-C49D47220141

Q42794018-517B1FD3-E65B-4362-B376-239CE4DB0F7F

Q42794018-738C70A3-1E7E-4F64-91CC-33A07AE67115

Q42794018-76BCE2A1-0332-433C-841C-3230BAF8E7B3

Q42794018-775F15D1-2F34-40A6-B812-B57713D0C488

Q42794018-86C73289-71E6-4CEF-B629-CEEDF068E666

Q42794018-8B2BA26A-9CC7-4F1D-92BD-2BCEA30245F6

P2888

Q42794018-9A17BB0A-2A65-4D1A-AF2D-E35BB799DDE5

P304

Q42794018-510DBBCF-D3EF-4D9D-BE6F-68E86A5F107A

P31

Q42794018-D47FDD9D-06C6-4439-939A-9E8D8B2266BC

P356

Q42794018-049BF68E-F3EB-4A7B-9704-A688F0DA6078

P407

Q42794018-E8B0A427-827A-457D-BE3E-47EFF8F82AC4

P433

Q42794018-A36BC5E0-1F0E-4237-B05F-94B530BCAB67

P478

Q42794018-A5EEBA88-4DA2-4AE0-8604-E57BE18F4961

P50

Q42794018-743E11F8-8DD6-44E2-ABB0-DA4904398CE5

Q42794018-B43890AA-E7A6-4B53-A34E-9CF7CD64CFFA

P577

Q42794018-2D67C744-604D-4C0C-9231-4C39D1964C91

P6179

Q42794018-28C45ECE-BEB3-4312-9F15-C8C77A280C7E

P698

Q42794018-C24FFF51-3932-4D81-A5A0-7C87249A062B

P356

P1433

Nature Medicine

P1476

Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.

@en

P2093

Alf Zerweck

http://www.w3.org/2001/XMLSchema#string

Andreas Beilhack

http://www.w3.org/2001/XMLSchema#string

Christine D Krempl

http://www.w3.org/2001/XMLSchema#string

Christoph Dürr

http://www.w3.org/2001/XMLSchema#string

Eva Jüttner

http://www.w3.org/2001/XMLSchema#string

Francesco Di Virgilio

http://www.w3.org/2001/XMLSchema#string

Frank Gärtner

http://www.w3.org/2001/XMLSchema#string

Jayanthi Ganesan

http://www.w3.org/2001/XMLSchema#string

Jürgen Finke

http://www.w3.org/2001/XMLSchema#string

Konrad Wilhelm

http://www.w3.org/2001/XMLSchema#string

P2888

P304

1434-1438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.2242

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012432821

http://www.w3.org/2001/XMLSchema#string

P698

21102458

http://www.w3.org/2001/XMLSchema#string